A clinical study of Alpha1H in combination with the currently used chemotherapy in bladder cancer
Latest Information Update: 09 Aug 2022
At a glance
- Drugs Alpha lactalbumin oleic acid (Primary) ; Epirubicin (Primary) ; Antineoplastics
- Indications Bladder cancer
- Focus Therapeutic Use
- Sponsors Hamlet Pharma AB
- 02 Aug 2022 Status changed from planning to discontinued, according to a Hamlet Pharma media release.
- 22 Jan 2021 According to a Hamlet Pharma media release, several more patients have been identified as potential candidates for this dose-escalation study
- 29 Sep 2020 New trial record